Chairman of the Board Mick McCormick stated, “The Board and employees have high confidence in Lori Woods that has been built through the years that she has served at IsoRay.
The study, “Long-term Quality of Life in Prostate Cancer Patients Treated with Cesium-131,” was published in the Journal of Radiation Oncology, Biology, Physics and was recently featured by Prostate Cancer News Today contributor Daniela Semedo.
While the Company conducts a search for a new Chief Executive Officer, industry veteran Lori Woods has been appointed interim Chief Executive Officer, effective June 4, 2018.
©2023. All rights reserved. Terms & Privacy | Privacy Policy
